IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

COSSU, MARIA VITTORIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.466
AS - Asia 2.157
EU - Europa 1.811
SA - Sud America 203
AF - Africa 112
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.767
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.342
CN - Cina 588
IT - Italia 562
SG - Singapore 552
GB - Regno Unito 338
VN - Vietnam 276
BD - Bangladesh 201
HK - Hong Kong 173
DE - Germania 172
BR - Brasile 144
RU - Federazione Russa 118
SE - Svezia 117
IN - India 109
FR - Francia 105
NL - Olanda 99
CA - Canada 98
ES - Italia 64
JP - Giappone 53
TR - Turchia 53
CI - Costa d'Avorio 46
FI - Finlandia 43
IE - Irlanda 39
KR - Corea 32
ID - Indonesia 30
CH - Svizzera 22
DK - Danimarca 22
BE - Belgio 21
CO - Colombia 19
PL - Polonia 19
AR - Argentina 17
AU - Australia 14
MX - Messico 14
PH - Filippine 14
TH - Thailandia 13
TW - Taiwan 13
AT - Austria 12
UA - Ucraina 11
ZA - Sudafrica 11
ET - Etiopia 10
GR - Grecia 9
CL - Cile 8
EC - Ecuador 8
SA - Arabia Saudita 8
UG - Uganda 7
CZ - Repubblica Ceca 6
KE - Kenya 6
MA - Marocco 6
UZ - Uzbekistan 6
BW - Botswana 5
KZ - Kazakistan 5
LT - Lituania 5
RO - Romania 5
BG - Bulgaria 4
IR - Iran 4
BO - Bolivia 3
CR - Costa Rica 3
IL - Israele 3
IQ - Iraq 3
LB - Libano 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TZ - Tanzania 3
BJ - Benin 2
BY - Bielorussia 2
DZ - Algeria 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
LK - Sri Lanka 2
MD - Moldavia 2
MW - Malawi 2
MY - Malesia 2
NG - Nigeria 2
PE - Perù 2
PK - Pakistan 2
SY - Repubblica araba siriana 2
TD - Ciad 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
LY - Libia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RE - Reunion 1
RS - Serbia 1
Totale 6.759
Salva come PNG Salva come JPEG
Città #
Singapore 328
Ashburn 293
Southend 195
Chandler 161
Milan 155
San Jose 152
Hong Kong 144
Dallas 138
Houston 105
Beijing 95
Santa Clara 85
Fairfield 84
Los Angeles 78
Frankfurt am Main 75
Ho Chi Minh City 73
Council Bluffs 72
New York 61
Hanoi 60
Seattle 60
The Dalles 57
Redwood City 53
Hefei 48
Abidjan 46
Shanghai 44
Toronto 44
Woodbridge 43
Boardman 42
Buffalo 41
Rome 41
Princeton 40
Ann Arbor 39
Wilmington 39
Dublin 35
Bengaluru 29
Cambridge 28
Lauterbourg 28
Phoenix 27
Nanjing 26
Helsinki 25
Munich 25
Tokyo 25
Istanbul 24
Jakarta 23
Moscow 22
London 20
São Paulo 20
Seoul 19
Brussels 17
Da Nang 17
Guangzhou 17
Rotterdam 17
Valencia 17
Dearborn 16
Chicago 15
Columbus 15
Warsaw 15
Bologna 14
Cangzhou 14
Des Moines 14
Dong Ket 13
Montreal 13
Naples 13
Nuremberg 13
Haiphong 12
Mumbai 12
Orem 12
Turin 12
Turku 12
Tianjin 11
Chennai 10
Ottawa 10
Taipei 10
Barcelona 9
Duncan 9
Fuzhou 9
Harringay 9
Nihon'odori 9
Palermo 9
Vienna 9
Washington 9
Athens 8
Atlanta 8
Biên Hòa 8
City of London 8
Fremont 8
Manchester 8
Munro 8
San Diego 8
Santiago de Cali 8
Shenyang 8
Shenzhen 8
Amsterdam 7
Florence 7
Hyderabad 7
Ober-Mörlen 7
Rio de Janeiro 7
Ankara 6
Brooklyn 6
Bến Tre 6
Catania 6
Totale 3.927
Salva come PNG Salva come JPEG
Nome #
Long term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicenter cohort of HIV1-infected, virologically suppressed patients 814
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status 319
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 293
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 281
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study 258
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 246
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study 240
Maraviroc reduces arterial stiffness in PI-treated HIV-infected patients 236
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy 233
Cohort profile : The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 227
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48weeks' observational data 221
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 211
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 209
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 204
An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents 204
Salvage therapy or simplification of salvage regimens with dolutegravir plus ritonavir-boosted darunavir dual therapy in highly cART-experienced subjects : an Italian cohort 199
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 185
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 183
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy 182
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced dimalsease: a trial emulation 179
Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects 176
Dolutegravir plus rilpivirine as a switch option in cART-experienced patients : 96-week data 164
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study 154
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 153
High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy 144
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 139
Treatment Experienced People Living with HIV switching to DOR/3TC/TDF in Outpatient Setting: Real-World Data on Tolerability and Cost Savings from an Italian Multicenter Cohort 130
Analyzing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicenter cohort of virologically-suppressed PLWHIV 127
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 119
Rifampicin drug monitoring in TB patients: new evidence for increased dosage? 116
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression 105
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 101
Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV 97
Evolution of causes of death in People with HIV between 2000 and 2023: a single center retrospective Study 65
Mental health, stigma and risk perception among early adopters of HIV PrEP with LA Cabotegravir in Italy: a multicenter cross-sectional and implementation study 35
High Rates of Drug Use and Chemsex Among PrEP Users and People with HIV in Milan Highlight Need for Targeted Interventions 22
The past that haunts: lessons from missed resistance history 18
Deltoid Administration of LAI-ART: Pharmacokinetic Implications When the Gluteal Site Is Not Feasible 18
Management of polypharmacy and potential drug-drug interactions in people with HIV and cancer: insights from a 4-year multidisciplinary clinic experience 11
null 3
Source of vaccine information and trust in health care professionals influence vaccine hesitancy in rheumatology patients in Italy 2
Totale 7.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.805
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022464 48 27 30 27 28 38 39 22 69 40 18 78
2022/2023543 57 78 53 62 30 88 12 45 42 14 38 24
2023/2024480 29 38 31 54 123 50 12 25 13 25 29 51
2024/20251.010 35 86 11 96 85 53 38 76 62 104 143 221
2025/20263.088 240 224 277 304 235 162 464 126 231 256 305 264
2026/2027141 141 0 0 0 0 0 0 0 0 0 0 0
Totale 7.023